About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:6202041
Allelic
Composition
Slc3a1tm1Jat/Slc3a1tm1Jat
Genetic
Background
involves: 129 * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Slc3a1tm1Jat mutation (0 available); any Slc3a1 mutation (38 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
renal/urinary system
• both males and females develop cystinuria (J:254981)
(J:254803)
• males show smooth muscle hypertrophy and basement membrane thickening of varying degrees
• males develop cysteine stones in the kidney but to a lesser degree than in the bladder
• males exhibit partial bladder outlet obstruction due to bladder stones
• bladder weight of males is 4-fold higher than in controls and males exhibit an increase in bladder mass
• mice accumulate urinary bladder stones at an average rate of 1 mm3/day (J:254803)
• mice treated with tiopronin, a sulfhydryl drug, or L-cystine dimethylester show no difference in cystine stone growth rate (J:254803)
• treatment with the pro-antioxidant sulforaphane has a modest effect on cystine stone growth while treatment with alpha-lipoic acid strongly suppresses stone growth (J:254803)
• males treated with alpha-lipoic acid before stone formation show delayed stone formation, lower overall stone volume accumulation, and form fewer stones (J:254803)
• males treated with alpha-lipoic acid after forming stones show reduced growth rate of existing stones and withdrawal of alpha-lipoic acid results in reversion of stone growth rate (J:254803)
• all males develop cysteine stones in the bladder, ranging in number of and size of stones (J:254981)
• however, females do not exhibit bladder stones (J:254981)
• intravesical pressure at capacity is lower in females but is normal in males
• both males and females show poor compliance (rate of intravesical pressure rise over the first 20% bladder volume) compared to controls, with males being worse than females
• both maximal contractile response and the rate of tension generation (contractile responses to neurogenic stimulation) are reduced in males, with mice responding between 20-30% of the response of controls
• the contractile responses to ATP (purinergic receptor agonist), KCl (smooth muscle membrane depolarization), and carbachol (muscarinic agonist) are also decreased in males
• females show slightly decreased contractile responses
• however, the contractile response to phenylephrine (alpha-adrenergic agonist) is normal
• the volume at capacity of bladder is lower in males
• females exhibit increased volume compared to males
• females exhibit decreased voiding pressure

homeostasis/metabolism
• both males and females develop cystinuria (J:254981)
(J:254803)

muscle
• males show smooth muscle hypertrophy and basement membrane thickening of varying degrees
• both maximal contractile response and the rate of tension generation (contractile responses to neurogenic stimulation) are reduced in males, with mice responding between 20-30% of the response of controls
• the contractile responses to ATP (purinergic receptor agonist), KCl (smooth muscle membrane depolarization), and carbachol (muscarinic agonist) are also decreased in males
• females show slightly decreased contractile responses
• however, the contractile response to phenylephrine (alpha-adrenergic agonist) is normal

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
cystinuria DOID:9266 OMIM:220100
J:254803 , J:254981


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory